Anbio Biotechnology (NNNN) stock
NNNNNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 11/30
$3.60−0.05 (-1.37%)
Close on Nov 18, 2026Market cap $518.01MP/E 24.5Yield –
Anbio Biotechnology operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was -$6.74M, down 423.9% from the year before.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$6.74M | -423.9% |
| FY2024 | Dec 31, 2024 | $2.08M | +131.6% |
| FY2023 | Dec 31, 2023 | $898.37K | -79.8% |
| FY2022 | Dec 31, 2022 | $4.45M | – |
See a number that looks wrong?